Psychological Evaluation After SCS Implantation
Long-term Psychological Evaluation of Patients With Implanted Spinal Cord Stimulator
1 other identifier
observational
60
1 country
1
Brief Summary
Spinal cord stimulation (SCS) is a therapeutic option for patients with chronic low back pain (CLBP) syndrome, when pharmacological, psychological, physical and occupational therapies or surgery fail to reduce symptoms. CLBP is a common disease with several negative consequences on the quality of life, work and activity ability and increased costs to the health-care system. We have therefore designed this observational study to assess global cognitive functioning in three different groups of patients: patients with chronic pain undergoing intervention (experimental group), patients with chronic pain following traditional therapies (comparison group) and healthy participants matched for age and schooling (healthy subjects). A neuropsychological assessment battery designed to assess global cognitive functioning, behavioral symptomatology, metacognition, quality of life, interoception, pain perception, self-efficacy, and coping styles will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2022
CompletedFirst Posted
Study publicly available on registry
November 22, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedNovember 22, 2022
November 1, 2022
12 months
November 14, 2022
November 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Global Cognitive Functioning - Montreal Cognitive Assessment
Montreal Cognitive Assessment provides screening of global cognitive functioning; it is composed of 12 subtasks exploring: memory; visuospatial abilities assessed by a clock-drawing task and by copying of a cube; executive functions assessed by means of a brief version of the Trail Making B task, a phonemic fluency task, and a two-item verbal abstraction task; attention, concentration and working memory assessed by means of a sustained attention task (target detection using tapping), a serial subtraction task, and forward and backward span tasks for digits; language assessed by a naming task with low-familiarity animals, repetition of two syntactically complex sentences and the above-mentioned phonemic fluency task; temporal and spatial orientation.
At patient's inclusion
Global Cognitive Functioning - Raven's Colored Progressive Matrices Test
The Raven's Colored Progressive Matrices Test assesses abstract reasoning abilities with nonverbal material. The test consists of 36 matrices, grouped into 3 sets of increasing difficulty. Each matrix has a missing piece that the subject must choose from six alternatives available. The total score ranges from 0 to 36 and is obtained by summing the number of correct answers.
At patient's inclusion
Secondary Outcomes (16)
Metacognition - Memory Assessment Clinics-Questionnaire
At patient's inclusion
Metacognition - Multifactorial Memory Questionnaire
At patient's inclusion
Metacognition - Adult Executive Functioning Inventory
At patient's inclusion
Quality of life
At patient's inclusion
Behavioral Symptomatology - Beck Depression Inventory
At patient's inclusion
- +11 more secondary outcomes
Study Arms (3)
Experimental group
Patients with chronic pain which failed standard therapies and with an implanted Spinal Cord Stimulator
Comparison group
Patients with chronic pain following traditional therapies, i.e. pharmacological, psychological, physical and occupational therapies or surgery.
Control group
Healthy volunteers matched for age and schooling to those included in the experimental group
Interventions
Spinal Cord Stimulation consists of the transcutaneous or surgical implantation of different types of electrodes in the epidural space; electrodes are then connected to an Implanted Pulse Generator that generates stimulating currents.
Standard therapies for chronic low back pain are pharmacological, psychological, physical and occupational therapies or surgery.
Eligibility Criteria
60 consecutive patients (20 per cohort) will be enrolled if they meet the inclusion criteria and no exclusion criteria as per cohort.
You may qualify if:
- age greater than 18 years
- presence of chronic pain treated with spinal cord stimulation (Experimental Group)
- presence of chronic pain receiving standard therapies (Comparison Group)
- healthy participants matched for age and schooling (Control Group).
You may not qualify if:
- consent denied
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Mater Domini
Catanzaro, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Federico Longhini, MD
Magna Graecia University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Intensive Care and Anesthesia Department
Study Record Dates
First Submitted
November 14, 2022
First Posted
November 22, 2022
Study Start
January 1, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
November 22, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- After study publication
- Access Criteria
- On reasonable scientific request by email the Principal Investigator
Anonymous data will be shared with al researchers after publication, on reasonable scientific request to the Principal Investigator